Yıl: 2023 Cilt: 22 Sayı: 2 Sayfa Aralığı: 99 - 106 Metin Dili: İngilizce DOI: 10.4274/eajem.galenos.2023.46872 İndeks Tarihi: 05-07-2023

Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin

Öz:
Aim: Using the end-tide carbon dioxide (ETCO2) level to predict the outcome of resuscitation may be misleading. This study investigated the usability of glial fibrillary acidic protein (GFAP) and copeptin levels measured at regular intervals during the resuscitation process as an alternative to the ETCO2 level in the prediction of resuscitation outcome. Materials and Methods: This study was prospectively conducted with patients who were resuscitated at the emergency department of a tertiary hospital. The sample included 31 patients, of whom 18 died and 23 had the return of spontaneous circulation (ROSC). ETCO2, GFAP, and copeptin values were measured at the beginning (1), 20th minute (2), and end (3) of resuscitation and statistically analyzed. Results: When calculated in percent units, the ETCO2 1-2 difference, ETCO2 2-3 difference, GFAP 1-2 difference, and copeptin 2-3 difference statistically significantly differed between the patients who died and those with ROSC (p<0.05). Conclusion: We observed that the GFAP and copeptin levels were not sufficient to guide the decision to terminate resuscitation when examined at the beginning of resuscitation, but changes in these copeptin levels measured in series could predict mortality.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Shibahashi K, Sugiyama K, Hamabe Y. A potential termination of resuscitation rule for EMS to implement in the field for out-of-hospital cardiac arrest: an observational cohort study. Resuscitation. 2018;130:28-32.
  • 2. Welbourn C, Efstathiou N. How does the length of cardiopulmonary resuscitation affect brain damage in patients surviving cardiac arrest? A systematic review. Scand J Trauma Resusc Emerg Med. 2018;26:77.
  • 3. Panchal AR, Bartos JA, Cabañas JG, Donnino MW, Drennan IR, Hirsch KG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 Suppl 2):366-468.
  • 4. Sandroni C, De Santis P, D’Arrigo S. Capnography during cardiac arrest. Resuscitation. 2018;132:73-7.
  • 5. Nolan JP, Sandroni C, Böttiger BW, Cariou A, Cronberg T, Friberg H, et al. European resuscitation council and European society of intensive care medicine guidelines 2021: post-resuscitation care. Resuscitation. 2021;161:220-69.
  • 6. Düring J, Annborn M, Cronberg T, Dankiewicz J, Devaux Y, Hassager C, et al. Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial. Critical Care. 2020;24:185.
  • 7. Lv H, Wang Q, Wu S, Yang L, Ren P, Yang Y, et al. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015;450:282-97.
  • 8. Helwig K, Seeger F, Hölschermann H, Lischke V, Gerriets T, Niessner M, et al. Elevated serum glial fibrillary acidic protein (GFAP) is associated with poor functional outcome after cardiopulmonary resuscitation. Neurocrit Care. 2017;27:68-74.
  • 9. Ok G, Aydın D, Erbüyün K, Gürsoy C, Taneli F, Bilge S, et al. Neurological outcome after cardiac arrest: a prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin. Turk J Med Sci. 2016;46:1459-68.
  • 10. Larsson IM, Wallin E, Kristofferzon ML, Niessner M, Zetterberg H, Rubertsson S. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. Resuscitation. 2014;85:1654-61.
  • 11. Aarsetøy R, Aarsetøy H, Hagve TA, Strand H, Staines H, Nilsen DWT. Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation. Front Cardiovasc Med. 2018;5:44.
  • 12. Christ-Crain M. Vasopressin and Copeptin in health and disease. Rev Endocr Metab Disord. 2019;20:283-94.
  • 13. Cakmak S, Sogut O, Albayrak L, Yildiz A. Serum Copeptin Levels Predict the Return of Spontaneous Circulation and the Short-Term Prognosis of Patients with Out-of-Hospital Cardiac Arrest: A Randomized Control Study. Prehosp Disaster Med. 2020;35:120-7.
  • 14. Broessner G, Hasslacher J, Beer R, Lackner P, Lehner GF, Harler U, et al. Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients. Resuscitation. 2015;89:75-80.
  • 15. Merchant RM, Topjian AA, Panchal AR, Cheng A, Aziz K, Berg KM, et al. Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 Suppl 2):337-57.
  • 16. Kaneko T, Kasaoka S, Miyauchi T, Fujita M, Oda Y, Tsuruta R, et al. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation. 2009;80:790-4.
  • 17. Paramanathan S, Grejs AM, Jeppesen AN, Søreide E, Kirkegaard H, Duez CHV. Copeptin as a Prognostic Marker in Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest. 2021;11:216-22.
  • 18. Ostadal P, Kruger A, Zdrahalova V, Janotka M, Vondrakova D, Neuzil P, et al. Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermia. Critical Care. 2012;16:187.
  • 19. Paiva EF, Paxton JH, O’Neil BJ. The use of end-tidal carbon dioxide (ETCO2) measurement to guide management of cardiac arrest: a systematic review. Resuscitation. 2018;123:1-7.
  • 20. Eckstein M, Hatch L, Malleck J, McClung C, Henderson SO. End-tidal CO2 as a predictor of survival in out-of-hospital cardiac arrest. Prehosp Disaster Med. 2011;26:148-50.
  • 21. Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D’Anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18:158-72.
APA tortum f, TEKİN E, Gur A, ÖZTÜRK N, Kasali K (2023). Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. , 99 - 106. 10.4274/eajem.galenos.2023.46872
Chicago tortum fatma,TEKİN Erdal,Gur Ali,ÖZTÜRK Nurinnisa,Kasali Kamber Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. (2023): 99 - 106. 10.4274/eajem.galenos.2023.46872
MLA tortum fatma,TEKİN Erdal,Gur Ali,ÖZTÜRK Nurinnisa,Kasali Kamber Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. , 2023, ss.99 - 106. 10.4274/eajem.galenos.2023.46872
AMA tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. . 2023; 99 - 106. 10.4274/eajem.galenos.2023.46872
Vancouver tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. . 2023; 99 - 106. 10.4274/eajem.galenos.2023.46872
IEEE tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K "Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin." , ss.99 - 106, 2023. 10.4274/eajem.galenos.2023.46872
ISNAD tortum, fatma vd. "Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin". (2023), 99-106. https://doi.org/10.4274/eajem.galenos.2023.46872
APA tortum f, TEKİN E, Gur A, ÖZTÜRK N, Kasali K (2023). Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. Eurasian Journal of Emergency Medicine, 22(2), 99 - 106. 10.4274/eajem.galenos.2023.46872
Chicago tortum fatma,TEKİN Erdal,Gur Ali,ÖZTÜRK Nurinnisa,Kasali Kamber Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. Eurasian Journal of Emergency Medicine 22, no.2 (2023): 99 - 106. 10.4274/eajem.galenos.2023.46872
MLA tortum fatma,TEKİN Erdal,Gur Ali,ÖZTÜRK Nurinnisa,Kasali Kamber Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. Eurasian Journal of Emergency Medicine, vol.22, no.2, 2023, ss.99 - 106. 10.4274/eajem.galenos.2023.46872
AMA tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. Eurasian Journal of Emergency Medicine. 2023; 22(2): 99 - 106. 10.4274/eajem.galenos.2023.46872
Vancouver tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin. Eurasian Journal of Emergency Medicine. 2023; 22(2): 99 - 106. 10.4274/eajem.galenos.2023.46872
IEEE tortum f,TEKİN E,Gur A,ÖZTÜRK N,Kasali K "Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin." Eurasian Journal of Emergency Medicine, 22, ss.99 - 106, 2023. 10.4274/eajem.galenos.2023.46872
ISNAD tortum, fatma vd. "Alternative Methods to Endtidal CO2 Predicting the Outcome of Resuscitation: Glial Fibrillary Acidic Protein and Copeptin". Eurasian Journal of Emergency Medicine 22/2 (2023), 99-106. https://doi.org/10.4274/eajem.galenos.2023.46872